Literature DB >> 32871750

Indocyanine Green Labels an Orthotopic Nude-Mouse Model of Very-Early Colon-Cancer Liver Metastases.

Yoshihiko Tashiro1,2,3, Hannah M Hollandsworth2,4, Hiroto Nishino1,2, Jun Yamamoto1,2, Siamak Amirfakhri2,4, Filemoni Filemoni2,4, Norihiko Sugisawa1,2, Takeshi Aoki3, Masahiko Murakami3, Robert M Hoffman1,2,4, Michael Bouvet5,4.   

Abstract

BACKGROUND/AIM: Near-infrared (NIR) fluorescence imaging using indocyanine green (ICG) is used to visualize colon-cancer liver metastases (CCLM) during surgery. The present study aimed to use ICG to visualize small CCLM in an orthotopic mouse model.
MATERIALS AND METHODS: A 3-mm fragment of HT29 human colon cancer was implanted to the liver of 5 athymic nude mice (nu/nu). The Pearl Trilogy Small Animal Fluorescence Imaging system was used 24 h after intravenous (IV) injection of 0.025 mg (0.25 mg/ml) ICG.
RESULTS: In four of the five mice, tumor fluorescence was detected. Small tumors (approximately 3 mm) were distinctly visualized with a minimal fluorescence liver signal, with a mean tumor to liver signal ratio of 1.81 (SD±0.167).
CONCLUSION: Small CCLM can be clearly identified by ICG fluorescence in an orthotopic nude-mouse model. This model is translatable to the clinic for the detection of occult early CCLM. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  ICG; colon cancer; detection; fluorescence; liver metastasis; orthotopic mouse model

Mesh:

Substances:

Year:  2020        PMID: 32871750      PMCID: PMC7652533          DOI: 10.21873/invivo.12038

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  18 in total

1.  Detection of hepatocellular carcinomas with near-infrared fluorescence imaging using indocyanine green: its usefulness and limitation.

Authors:  Yoshifumi Morita; Takanori Sakaguchi; Naoki Unno; Yasushi Shibasaki; Atsushi Suzuki; Kazuhiko Fukumoto; Keisuke Inaba; Satoshi Baba; Yasuo Takehara; Shohachi Suzuki; Hiroyuki Konno
Journal:  Int J Clin Oncol       Date:  2011-12-27       Impact factor: 3.402

Review 2.  Orthotopic is orthodox: why are orthotopic-transplant metastatic models different from all other models?

Authors:  R M Hoffman
Journal:  J Cell Biochem       Date:  1994-09       Impact factor: 4.429

3.  Patient-derived orthotopic xenografts: better mimic of metastasis than subcutaneous xenografts.

Authors:  Robert M Hoffman
Journal:  Nat Rev Cancer       Date:  2015-08       Impact factor: 60.716

4.  Determination of the surgical margin in laparoscopic liver resections using infrared indocyanine green fluorescence.

Authors:  Takeshi Aoki; Masahiko Murakami; Tomotake Koizumi; Kazuhiro Matsuda; Akira Fujimori; Tomokazu Kusano; Yuta Enami; Satoru Goto; Makoto Watanabe; Koji Otsuka
Journal:  Langenbecks Arch Surg       Date:  2018-06-18       Impact factor: 3.445

5.  Oral Recombinant Methioninase Overcomes Colorectal-cancer Liver Metastasis Resistance to the Combination of 5-Fluorouracil and Oxaliplatinum in a Patient-derived Orthotopic Xenograft Mouse Model.

Authors:  Hiromichi Oshiro; Yasunori Tome; Tasuku Kiyuna; Sang Nam Yoon; Thinzar M Lwin; Qinghong Han; Yuying Tan; Kentaro Miyake; Takashi Higuchi; Norihiko Sugisawa; Yuki Katsuya; Jun Ho Park; Zhiying Zang; Sahar Razmjooei; Michael Bouvet; Bryan Clary; Shree Ram Singh; Fuminori Kanaya; Kotaro Nishida; Robert M Hoffman
Journal:  Anticancer Res       Date:  2019-09       Impact factor: 2.480

Review 6.  Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic.

Authors:  R M Hoffman
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

7.  Intraoperative US in patients undergoing surgery for liver neoplasms: comparison with MR imaging.

Authors:  Dushyant V Sahani; Sanjeeva P Kalva; Kenneth K Tanabe; Sikandar M Hayat; Mary J O'Neill; Elkan F Halpern; Sanjay Saini; Peter R Mueller
Journal:  Radiology       Date:  2004-07-23       Impact factor: 11.105

8.  Image-guided liver mapping using fluorescence navigation system with indocyanine green for anatomical hepatic resection.

Authors:  Takeshi Aoki; Daisuke Yasuda; Yoshinori Shimizu; Masanori Odaira; Takashi Niiya; Tomokazu Kusano; Keitaro Mitamura; Ken Hayashi; Noriyuki Murai; Tomotake Koizumi; Hirohisa Kato; Yuta Enami; Mitsuharu Miwa; Mitsuo Kusano
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

9.  Detection of hepatic metastases from colorectal carcinoma: comparison of histopathologic features of anatomically resected liver with results of preoperative imaging.

Authors:  Kazuhiko Nomura; Masumi Kadoya; Kazuhiko Ueda; Yasunari Fujinaga; Shiro Miwa; Shin-ichi Miyagawa
Journal:  J Clin Gastroenterol       Date:  2007-09       Impact factor: 3.062

Review 10.  Current state of the art imaging approaches for colorectal liver metastasis.

Authors:  Bita Hazhirkarzar; Pegah Khoshpouri; Mohammadreza Shaghaghi; Mounes Aliyari Ghasabeh; Timothy M Pawlik; Ihab R Kamel
Journal:  Hepatobiliary Surg Nutr       Date:  2020-02       Impact factor: 7.293

View more
  3 in total

1.  Ligation Method to Specifically Label a Liver Segment With Indocyanine Green in an Orthotopic Nude-Mouse Liver-Metastasis Model.

Authors:  Hiroto Nishino; Hannah M Hollandsworth; Yoshihiko Tashiro; Jun Yamamoto; Siamak Amirfakhri; Filemoni Filemoni; Norihiko Sugisawa; Robert M Hoffman; Michael Bouvet
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

2.  A Novel Color-Coded Liver Metastasis Mouse Model to Distinguish Tumor and Adjacent Liver Segment.

Authors:  Hiroto Nishino; Hannah M Hollandsworth; Siamak Amirfakhri; Yoshihiko Tashiro; Jun Yamamoto; Michael A Turner; Thinzar M Lwin; Bernhard B Singer; Robert M Hoffman; Michael Bouvet
Journal:  J Surg Res       Date:  2021-04-10       Impact factor: 2.417

3.  Diagnostic imaging in near-infrared photoimmunotherapy using a commercially available camera for indocyanine green.

Authors:  Fuyuki F Inagaki; Daiki Fujimura; Aki Furusawa; Ryuhei Okada; Hiroaki Wakiyama; Takuya Kato; Peter L Choyke; Hisataka Kobayashi
Journal:  Cancer Sci       Date:  2021-02-05       Impact factor: 6.518

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.